ArticleProstate cancer and prostatic diseases2026
Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database.
Article in Prostate cancer and prostatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrior studies have reported genitourinary toxicity associated with transurethral resection of the prostate after radiation therapy (XRT) for localized prostate cancer (PCa). However, treatment options for benign prostatic hyperplasia have expanded exponentially within the last decade. Using a more contemporary cohort and analyzing newer bladder outlet obstruction procedures (BOOP), this study aims to compare the rates of genitourinary toxicity in men who have undergone BOOP after versus before XRT for PCa.
methodsWe conducted a retrospective cohort study using the TriNetX network. We identified 447 patients receiving BOOP after XRT (Cohort A) and 1 504 patients receiving BOOP before XRT (Cohort B). Cohorts were propensity-score matched for demographic, comorbidities and relevant medications. We stratified the analysis by type of procedure-minimally invasive surgical techniques (MISTs) or resective surgery (RS). Statistical analysis reporting risk ratios (RR) and 95% confidence intervals (95% CI) was conducted.
resultsEach cohort consisted of 411 matched patients who were well balanced after PSM (SMD < 0.1). Patients in Cohort A had an increased risk of stress urinary incontinence [RR 4.29, 95% CI (2.19, 8.41)], urge urinary incontinence[RR 2.09, 95% CI (1.25, 3.49)], mixed urinary incontinence[RR 2.49, (1.21, 5.11)], urinary retention [RR 2.38, 95% CI (1.54, 3.68)], bladder neck contracture [RR 2.56, 95% CI(1.39, 4.68)] and urethral strictures [RR 3.28, 95% CI (1.83-5.88)] compared to patients in Cohort B. Outcomes for MISTs after versus before XRT were limited by small sample size but suggested no difference in the risk of genitourinary toxicity. Compared to RS before XRT, RS after XRT was associated with an increased risk of stress incontinence, urinary retention, bladder neck contracture, and urethral strictures.
conclusionMen with a history of BOOP undergoing XRT have less genitourinary toxicity than those undergoing XRT after. To limit such toxicity, urologists should evaluate concomitant benign prostatic hyperplasia and consider BOOP before patients undergo XRT.
Identifiers
42203958What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.